BCS Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,498
Closed -$620K 261
2025
Q4
$620K Buy
6,498
+3,316
+104% +$325K 0.06% 203
2025
Q3
$311K Sell
3,182
-1,311
-29% -$136K 0.07% 194
2025
Q2
$483K Buy
4,493
+1,161
+35% +$117K 0.1% 159
2025
Q1
$336K Sell
3,332
-1,013
-23% -$102K 0.09% 185
2024
Q4
$388K Buy
+4,345
New +$382K 0.1% 175

Other funds holding BSX

BCS Wealth Management's BSX Position: Q1 2026 in Review

BCS Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,498 shares — an estimated $620K sold.

BCS Wealth Management first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $620K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • BCS Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • BCS Wealth Management sold 6,498 Boston Scientific shares in Q1 2026, an estimated $620K.
  • BCS Wealth Management first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
  • BCS Wealth Management's Boston Scientific position peaked at $620K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BCS Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.